Daisuke Hirate

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.

Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.

Journal: Anticancer research

Published: March 13, 2026

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Journal: Japanese journal of clinical oncology

Published: February 16, 2026

Chemotherapy-related hand-foot syndrome and hand-foot skin reaction: a review of management and possible approaches for Asian patients by the Japanese pharmacist-led oncodermatology study team.

Chemotherapy-related hand-foot syndrome and hand-foot skin reaction: a review of management and possible approaches for Asian patients by the Japanese pharmacist-led oncodermatology study team.

Journal: International journal of clinical oncology

Published: July 11, 2025

Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team.

Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team.

Journal: International journal of clinical oncology

Published: July 04, 2025

Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study.

Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: November 25, 2024

The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.

The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: December 22, 2023

Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study.

Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study.

Journal: BMJ open

Published: November 22, 2023

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.

Journal: Scientific reports

Published: June 22, 2023

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment.

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment.

Journal: Scientific reports

Published: March 22, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026